Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors

Maria Letizia Giardino Torchia, Elena Ciaglia, Anna Maria Masci et al. · 2010

Read Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors by Maria Letizia Giardino Torchia, Elena Ciaglia, Anna Maria Masci et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011052.txt.

Description

Maria Letizia Giardino Torchia, Elena Ciaglia, Anna Maria Masci and co-authors published this HIV drug study in PLOS ONE in 2010. HIV protease inhibitors block the virus's assembly enzyme, but they also reshape immune responses by routes unrelated to the virus. The authors examined how five of these drugs affect the making of dendritic cells, the instructors of the immune system, and their dialogue with natural killer cells.

Blood monocytes from healthy donors were grown toward dendritic cells in the presence of each drug. The drugs differed in effect, but several produced immature cells with lowered display and co-stimulatory molecules, and one in particular prevented normal maturation and cytokine release. Torchia and colleagues map an off-target immune footprint of a major drug class. That footprint may explain some side effects and could be exploited to calm unwanted inflammation.

Catalog record

CREATORMaria Letizia Giardino Torchia, Elena Ciaglia, Anna Maria Masci et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011052

Browse the full library · About the Tower of Babel